Appraisal of pyrrole as connecting unit in hydroxamic acid based histone deacetylase inhibitors: Synthesis, anticancer evaluation and molecular docking studies-Reference-Cited by-同舟云学术

Appraisal of pyrrole as connecting unit in hydroxamic acid based histone deacetylase inhibitors: Synthesis, anticancer evaluation and molecular docking studies

Published:2021-09 Issue: Volume:1240 Page:130590
ISSN:0022-2860
Container-title:Journal of Molecular Structure
language:en
Short-container-title:Journal of Molecular Structure

Author:

Singh Avineesh,Patel Vijay K.,Rajak Harish

Funder

Science and Engineering Research Board

Council of Scientific & Industrial Research

Indian Council of Medical Research

Publisher

Elsevier BV

Subject

Inorganic Chemistry,Organic Chemistry,Spectroscopy,Analytical Chemistry

Reference42 articles.

1. A structural insight into hydroxamic acid based histone deacetylase inhibitors for the presence of anticancer activity;Rajak;Curr. Med. Chem.,2014

2. Peptide based macrocycles: selective histone deacetylase inhibitors with antiproliferative activity;Rajak;Curr. Med. Chem.,2013

3. Histone deacetylase inhibitors in clinical studies as templates for new anticancer agents;Mottamal;Molecules (Basel, Switzerland),2015

4. Histone deacetylase inhibitors;Price;Expert Opin. Ther. Patents,2007

5. Identifying novel type ZBGs and nonhydroxamate HDAC inhibitors through a SVM based virtual screening approach;Liu;Mol. Inform.,2010

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Leveraging a rationally designed veliparib-based anilide eliciting anti-leukemic effects for the design of pH-responsive polymer nanoformulation;European Journal of Medicinal Chemistry;2024-07

2. Heterocyclic Compounds and their Derivatives with Potential Anticancer Activity;Indian Journal of Pharmaceutical Education and Research;2024-03-06

3. Recent Developments of Hydroxamic Acid Hybrids as Potential Anti-Breast Cancer Agents;Future Medicinal Chemistry;2024-01-31

4. Hydroxamic acid hybrids: Histone deacetylase inhibitors with anticancer therapeutic potency;European Journal of Medicinal Chemistry;2023-12

5. Multi-targeted HDAC Inhibitors as Anticancer Agents: Current Status and Future Prospective;Current Medicinal Chemistry;2023-07